TRV Travelers Companies (The)
Best-in-class underwriter priced for peak returns; mid-teens normalized ROE supports less than today's price.
The story
Travelers is a top-tier US commercial and personal P&C franchise with disciplined underwriting, conservative reserving, and a large high-quality fixed-income portfolio now reinvesting at higher yields. The trailing 25% ROE reflects a peak: benign catastrophe losses, favorable prior-year reserve development, and the tail of a hard pricing market. Commercial pricing is now softening, so combined ratios should drift back up. Over a full cycle, Travelers earns mid-teens returns on moderate leverage, and its balance sheet is strong.
Normalized ROE of 15.5% sits between TRV's 10-year average of about 12-13% and today's 25% peak, crediting higher net investment income but assuming normal catastrophe loads and softer commercial pricing. Book growth is about 7% in year one after buybacks and dividends, fading to 4%, below the risk-free rate. Beta of 0.82 is slightly under the industry anchor because TRV's earnings are diversified and lightly levered.
Value drivers
| Return on equity (normalized) | 15.5% |
| Book-value growth (Y1) | 7.0% |
| Terminal book growth | 4.0% |
| Beta | 0.82 |
| Failure probability | 1.0% |
| Cost of equity | 8.9% |
Valuation bridge
| PV of excess returns | 12.03B |
| PV of terminal excess | 9.91B |
| Equity value | 54.29B |
| ÷ shares → per share | $260.28 |
News
neutral +0.10 · 8 articles
- Travelers Companies (TRV) As Reserve Strength Keeps The Valuation Debate Open
- Global Commercial Pricing Soft: 4 P&C Insurers to Protect Portfolio
- High Interest Rates Are Good News for These 4 Insurance Dividend Stocks
- How AIG Is Protecting Underwriting Quality as Property Pricing Softens
- 4 Insurance Stocks With Two Big Profit Engines Backing the Dividend
- Is The Hanover Insurance Group (THG) a Great Value Stock Right Now?
- The Nasdaq Set a Record and the Dow Lost 270 Points on the Same Morning
- 3 P&C Insurers Stand to Gain From Higher Fixed-Income Yields
Projected excess returns on equity
| Yr | Book equity | ROE | Excess return | PV |
|---|---|---|---|---|
| 1 | 32.89B | 15.5% | 2.19B | 2.01B |
| 2 | 35.20B | 15.0% | 2.16B | 1.82B |
| 3 | 37.54B | 14.5% | 2.11B | 1.63B |
| 4 | 39.92B | 14.0% | 2.04B | 1.45B |
| 5 | 42.32B | 13.4% | 1.94B | 1.27B |
| 6 | 44.71B | 12.9% | 1.82B | 1.09B |
| 7 | 47.10B | 12.4% | 1.67B | 923.21M |
| 8 | 49.45B | 11.9% | 1.50B | 760.96M |
| 9 | 51.76B | 11.4% | 1.30B | 607.11M |
| 10 | 54.00B | 10.9% | 1.08B | 462.48M |
Key risks
- Commercial P&C pricing softening compresses underwriting margins faster than expected
- Severe catastrophe year or social-inflation-driven adverse reserve development in liability lines
- Falling interest rates reduce reinvestment yields and net investment income
Catalysts
- Continued favorable reserve releases and low cat losses supporting above-normal ROE for longer
- Aggressive buybacks at elevated capital levels boosting per-share book growth